NYSE:PRGO - Perrigo Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $63.46 -1.93 (-2.95 %) (As of 11/15/2018 06:15 AM ET)Previous Close$65.39Today's Range$62.61 - $65.3752-Week Range$62.61 - $95.93Volume1.43 million shsAverage Volume1.29 million shsMarket Capitalization$8.91 billionP/E Ratio12.87Dividend Yield1.16%Beta0.66 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Receive PRGO News and Ratings via Email Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolNYSE:PRGO Previous Symbol CUSIP71429010 Webwww.perrigo.com Phone353-1709-4000 Debt Debt-to-Equity Ratio0.54 Current Ratio1.85 Quick Ratio1.26 Price-To-Earnings Trailing P/E Ratio12.87 Forward P/E Ratio13.68 P/E Growth2.22 Sales & Book Value Annual Sales$4.95 billion Price / Sales1.74 Cash Flow$7.7296 per share Price / Cash8.21 Book Value$41.66 per share Price / Book1.52 Profitability EPS (Most Recent Fiscal Year)$4.93 Net Income$119.60 million Net Margins2.54% Return on Equity11.32% Return on Assets5.96% Miscellaneous Employees10,400 Outstanding Shares135,860,000Market Cap$8.91 billion OptionableOptionable Perrigo (NYSE:PRGO) Frequently Asked Questions What is Perrigo's stock symbol? Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO." How often does Perrigo pay dividends? What is the dividend yield for Perrigo? Perrigo declared a quarterly dividend on Wednesday, October 31st. Shareholders of record on Friday, November 30th will be paid a dividend of $0.19 per share on Tuesday, December 18th. This represents a $0.76 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Thursday, November 29th. View Perrigo's Dividend History. How were Perrigo's earnings last quarter? Perrigo Company PLC (NYSE:PRGO) released its earnings results on Thursday, November, 8th. The company reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.05 by $0.04. The firm had revenue of $1.13 billion for the quarter, compared to analysts' expectations of $1.17 billion. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. Perrigo's quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.39 EPS. View Perrigo's Earnings History. When is Perrigo's next earnings date? Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Perrigo. What guidance has Perrigo issued on next quarter's earnings? Perrigo issued an update on its FY18 earnings guidance on Thursday, November, 8th. The company provided earnings per share guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS. What price target have analysts set for PRGO? 15 equities research analysts have issued 1-year price targets for Perrigo's shares. Their predictions range from $63.00 to $110.00. On average, they expect Perrigo's share price to reach $82.7333 in the next twelve months. This suggests a possible upside of 30.4% from the stock's current price. View Analyst Price Targets for Perrigo. What is the consensus analysts' recommendation for Perrigo? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo. Has Perrigo been receiving favorable news coverage? Headlines about PRGO stock have been trending somewhat positive on Thursday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Perrigo earned a coverage optimism score of 1.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term. Who are some of Perrigo's key competitors? Some companies that are related to Perrigo include Takeda Pharmaceutical (TKPYY), ASTELLAS PHARMA/ADR (ALPMY), Alexion Pharmaceuticals (ALXN), Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), Mylan (MYL), BioMarin Pharmaceutical (BMRN), UCB (UCBJF), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Bausch Health Companies (BHC), Jazz Pharmaceuticals (JAZZ), Genmab A/S (GNMSF) and Sarepta Therapeutics (SRPT). Who are Perrigo's key executives? Perrigo's management team includes the folowing people: Mr. Ronald L. Winowiecki, Chief Financial Officer (Age 52)Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 58)Mr. Sharon Kochan, Exec. VP & Pres of Branded Consumer Healthcare and International (Age 50)Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 62)Mr. Murray S. Kessler, CEO, Pres & Director (Age 58) Who are Perrigo's major shareholders? Perrigo's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (8.10%), Franklin Resources Inc. (6.79%), BlackRock Inc. (6.08%), Victory Capital Management Inc. (2.29%), Ceredex Value Advisors LLC (2.07%) and Iridian Asset Management LLC CT (1.41%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Judy L Brown, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo. Which institutional investors are selling Perrigo stock? PRGO stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Los Angeles Capital Management & Equity Research Inc., BlackRock Inc., Deutsche Bank AG, Migdal Insurance & Financial Holdings Ltd., Crawford Investment Counsel Inc., Panagora Asset Management Inc. and Mitsubishi UFJ Trust & Banking Corp. Company insiders that have sold Perrigo company stock in the last year include John Wesolowski, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo. Which institutional investors are buying Perrigo stock? PRGO stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Iridian Asset Management LLC CT, Ceredex Value Advisors LLC, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, First Eagle Investment Management LLC, Franklin Resources Inc., Victory Capital Management Inc. and Menora Mivtachim Holdings LTD.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo. How do I buy shares of Perrigo? Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Perrigo's stock price today? One share of PRGO stock can currently be purchased for approximately $63.46. How big of a company is Perrigo? Perrigo has a market capitalization of $8.91 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe. What is Perrigo's official website? The official website for Perrigo is http://www.perrigo.com. How can I contact Perrigo? Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected] MarketBeat Community Rating for Perrigo (NYSE PRGO)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 634 (Vote Outperform)Underperform Votes: 599 (Vote Underperform)Total Votes: 1,233MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/15/2018 by MarketBeat.com StaffFeatured Article: How is Preferred Stock Different from Common Stock?